title: Balancing cyclosporine A nephrotoxicity and rejection late after adult liver transplantation.
authors.affiliation: Toronto Hospital, University of Toronto, Ontario, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Paul
authors.forename: G A
authors.initials: GA
authors.lastname: Levy
authors.forename: P D
authors.initials: PD
authors.lastname: Greig
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D016572:Cyclosporine; D003404:Creatinine; D008775:Methylprednisolone